Figure 3
Vaccinated, allogeneic BMT recipients have slower tumor growth. MB49 was placed on BMT recipients on day 42 and measured for growth in syngeneic and allogeneic BMT recipients who received 5 × 106 cells for their DLI on days 14 and 28 with or without a male DC vaccine, 5 or 6 mice/group. *P < .01.
